Conductive keratoplasty for the treatment of presbyopia: comparative study between post- and non-LASIK eyes by Tomita, Minoru et al.
Clinical Ophthalmology
© 2011 Tomita et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article  
which permits unrestricted noncommercial use, provided the original work is properly cited.
Clinical Ophthalmology 2011:5 231–237
Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
231
OriginAL reseArCh
open access to scientific and medical research
Open Access Full Text Article
DOI: 10.2147/OPTH.S16791
Conductive keratoplasty for the treatment  
of presbyopia: comparative study between  
post- and non-LAsiK eyes
Minoru Tomita* 
Miyuki Watabe* 
Mitsutoshi ito 
Tadahiko Tsuru
shinagawa LAsiK Center,  
Chiyoda-ku, Tokyo, Japan
*Minoru Tomita and Miyuki Watabe 
contributed equally to this study
Correspondence: Minoru Tomita
shinagawa LAsiK Center, Yurakucho 
iTOCiA 14F, 2-7-1 Yurakucho,  
Chiyoda-ku, Tokyo 100-0006, Japan
Tel +81 3 5221 2207
Fax +81 3 5221 8138
email tomita@shinagawa.com
Purpose: To evaluate the efficacy and safety of conductive keratoplasty (CK) for the treatment 
of presbyopia and analyze the differences in the effects between post- and non-laser in situ 
keratomileusis (LASIK) eyes. Clinical preoperative factors that could affect the predictability 
of CK were also analyzed.
Methods: The visual and refractive outcomes of CK for the treatment of presbyopia in 14 eyes 
of 13 post-LASIK patients (post-LASIK group mean age 50.9 ± 3.4 years) and those of 25 eyes 
of 25 non-LASIK patients (non-LASIK group mean age 52.4 ± 4.0 years) were studied. The 
clinical efficacy, safety, stability, and predictability of CK were statistically evaluated.
Results: The mean (logarithm of the minimum angle of resolution [logMAR] ± standard 
deviation [SD]) of preoperative uncorrected near visual acuity (UNVA) and manifest refraction 
spherical equivalent (MRSE) were 0.64 ± 0.25 diopter (D) and 0.35 ± 0.48 D, respectively, in the 
post-LASIK group, and 0.71 ± 0.20 D and 0.64 ± 0.61 D, respectively, in the non-LASIK group. 
At 6 months after CK, the mean UNVA and MRSE were 0.07 ± 0.13 D and −1.59 ± 0.86 D, 
respectively, in the post-LASIK group, and 0.07 ± 0.12 D and −1.06 ± 0.56 D, respectively, in 
the non-LASIK group. At 1 year after CK, the mean UNVA and MRSE were 0.30 ± 0.17 D 
and −0.58 ± 0.52 D, respectively, in the post-LASIK group, and 0.28 ± 0.34 D and −1.56 ± 0.62 D, 
respectively, in the non-LASIK group. There was no significant difference between the two 
groups in either factor at 6 months postoperative (Student’s t-test, P . 0.05). At 1 year after 
CK, all the treated eyes maintained corrected distance visual acuity better than −0.08 (logMAR). 
The mean cylindrical errors were within ±1.00 D in 100% of the post-LASIK and non-LASIK 
patients. As for the preoperative clinical factors evaluated for their potential relationship to the 
predictability of CK, none showed significant effect on the clinical outcomes.
Conclusion: CK is demonstrated to be safe for the treatment of presbyopia in post-LASIK 
patients as well as in non-LASIK patients, though needed longer observation in terms of factors 
affecting predictability.
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Introduction
Presbyopia has been known as one of the most common aging phenomena of the eye, 
leading to loss of near vision, especially in emmetropic or hyperopic eyes.   Conventional 
management is to use reading glasses to correct presbyopia. In recent years, a number 
of treatments have been developed to meet the needs of patients wanting to be free from 
reading glasses. These treatments include bifocal or multifocal contact lenses,   monovision 
using monofocal lenses, and multifocal laser in situ keratomileusis (LASIK).1–6
US Food and Drug Administration (FDA) clinical trials in 2002 demon-
strated that   conductive keratoplasty (CK) was effective for the treatment of low to Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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  moderate h  yperopia.7 Since then, the use of this technique has 
expanded to treat h  yperopic astigmatism, keratoconus, and cor-
neal ectasia (keratoectasia) after LASIK.8,9 In 2004, the results 
of a 1-year clinical trial demonstrated that CK was effective 
also for the treatment of presbyopia.10 However, there have been 
only a few studies on the effect of CK for presbyopia.11,12
In CK, a thin probe is inserted into the cornea, and radio 
waves are used to make heat coagulation of the corneal 
stroma to alter the corneal curvature. CK makes a myopic 
shift of the treated eye and improves near vision. This 
  technique is now widely used, but there have not been many 
reports on the effectiveness of CK on post-LASIK eyes. 
In this study, we compared the visual and refractive outcomes 
of CK t  reatment on post-LASIK and non-LASIK eyes and 
analyzed the clinical outcomes.
Methods
eligibility of the patients and pre-  
and postoperative examinations
The eligibility requirements for CK at our clinic were as 
  follows: patients age over 40 years, only those patients 
who do not drive long hours and who do not require perfect 
  distance vision, eyes with −1.0 diopter (D) to +1.5 D of 
sphere (manifest and cycloplegic), equivalent to −0.75 D 
or less than −0.75 D of cylinder, and corneal thickness of 
400 µm or more at the center of the cornea and 560 µm or 
more at the 6 mm peripheral area. Patients with pacemakers 
and/or cochlear implants were excluded from CK surgery.
In this study, the preoperative examinations included 
uncorrected distance and near visual acuity (UDVA 
and UNVA, respectively), corrected distance and near 
visual   acuity (CDVA and CNVA, respectively), binocular 
  uncorrected distance and near visual acuity (binocular UDVA 
and binocular UNVA, respectively), distance and near mani-
fest refraction and cycloplegic refraction, distance and near 
bilateral visual acuity, intraocular pressure, corneal topogra-
phy using TMS-4® (Tomey Corp, Nagoya, Japan), ultrasonic 
pachymetry, endothelial cell density, slit lamp examinations, 
dominant eye tests, and monovision tests.
Postoperative examinations included UDVA, UNVA, 
CDVA, and CNVA (operated eyes only), binocular UDVA 
and binocular UNVA, distant manifest refraction, corneal 
topography, and slit lamp examinations.
The candidates also went through a monovision test 
using trial glasses (loose lens test). We used three different 
powers of lenses for the monovision trial, +1.00 D, +1.75 D, 
and +2.50 D, in order to evaluate the required correction and 
also the patients’ ability to adapt to monovison. Candidates 
who were not satisfied with the trial glasses were allowed to 
go through a similar test using contact lenses. All patients 
were informed that presbyopic symptoms might not be 
improved after CK.
In addition, the post-LASIK candidates were required 
to have waited at least 3 months after LASIK before 
  undergoing CK.
Statistical analyses were conducted using Student’s t-test, 
Spearman’s correlation coefficient by rank, or Pearson’s 
  correlation coefficient as appropriate. For all tests, a P value 
less than 0.05 was considered statistically significant.
surgical procedure
After the preoperative slit lamp examinations were 
  completed, one drop of 0.4% oxybuprocaine hydrochloride 
ophthalmic solution (Benoxil®, Santen Pharmaceutical, 
Osaka, Japan) was instilled, followed by one drop of 0.5% 
moxifloxacin hydrochloride ophthalmic solution (Vegamox®, 
Alcon Japan, Tokyo, Japan) and 4% lidocaine ophthalmic 
solution (Xylocaine®, AstraZeneca PLC, Osaka).
Under the microscopic observation, the pupil center of the 
cornea was marked with a marker (BD Visimark™ Gentian Violet 
Marking Pad, BD Ophthalmic System, Waltham, MA, USA), 
then the CK template (NearVison® CK or   OptiPoint® Corneal 
Template, Refractec, Inc., CA, USA) was applanated at the 
center of the template and matched with the corneal center.
According to the surgical nomogram of the manufacturer, 
the probe was inserted into the holes of the template. For the 
post-LASIK eyes, the intended correction was reduced by 
20%–30% from the standard nomogram, because it has been 
reported that the effects of CK are exaggerated in post-LASIK 
eyes.13
After completing the procedure, the template was 
removed and one drop of moxifloxacin hydrochloride, 0.3% 
sodium hyaluronate ophthalmic solution (Hyalein® Mini, 
Santen Pharmaceutical, Osaka), and 0.1% dexamethasone 
sodium meta-sulfobenzoate ophthalmic solution (D⋅E⋅X®, 
Nitto Medic, Toyama, Japan) were instilled.
The patients were instructed to rest for 20 minutes 
before receiving the doctor’s postoperative examination. 
If no problems were found, one drop of sodium hyaluronate 
  ophthalmic solution was instilled and the patients were 
allowed to go home.
Postoperative care
On the day of the surgery, the patients were instructed 
to instil one drop of 0.1% fluorometholone ophthalmic 
solution (Flumetholon®, Santen Pharmaceutical, Osaka), Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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0.5% moxifloxacin hydrochloride ophthalmic solution, 
and 0.3% sodium hyaluronate ophthalmic solution once 
every hour.
The patients were instructed to visit our clinic for 
  postoperative examinations at 1 day, 1 week, 1 month, 
3 months, 6 months, and 1 year after surgery. From the day 
after the operation, one drop of fluorometholone, moxifloxa-
cin hydrochloride, and 0.1% hyaluronate sodium ophthalmic 
solution (Tearbalance®, Senju Pharmaceutical, Osaka) was 
administrated.
Results
Patients’ demography
A total of 39 eyes of 38 patients who underwent CK between 
April 2007 and June 2009 were included in this study. Of 
those, 25 eyes of 25 patients had no history of ophthalmic 
surgery (9 males and 16 females) and 14 eyes of 13 patients 
had received LASIK before CK (8 males and 5 females). One 
of the post-LASIK patients underwent corrective treatment 
for residual hyperopia from the previous LASIK on one eye, 
and the fellow eye was treated for presbyopia. The mean age 
of the non-LASIK patients was 52.4 ± 4.0 years (n = 25) and 
of the post-LASIK patients was 50.9 ± 3.4 years (n = 13). 
For the post-LASIK patients, the mean period between their 
LASIK operation and CK was 408.9 ± 315.4 days (range 
110–948 days). The corneal flap thickness of the previous 
LASIK was between 85 µm and 110 µm. The mean attempted 
correction was −1.60 ± 0.76 D in the non-LASIK patients, 
and −1.27 ± 0.74 D in the post-LASIK patients.
All of the patients received postoperative examinations 
at 1 day, 1 week, and 1 month after CK. Sixty-four percent 
(n = 16), 36.0% (n = 9), and 8.0% (n = 2) of the non-LASIK 
patients and 76.9% (n = 10), 53.8% (n = 7), and 23.1% 
(n = 3) of the post-LASIK patients received examinations at 
3 months, 6 months, and 1 year after CK, respectively. As the 
number of the patients who attended the 1-year postoperative 
examination was very small, only numerical values were 
included without statistical analysis in this study.
Visual acuity
The mean (±standard deviation [SD]) UNVA (logarithm 
of the minimum angle of resolution [logMAR]) before CK 
and 1 week, 1 month, 3 months, 6 months, and 1 year after 
CK was 0.64 ± 0.25, 0.10 ± 0.20, 0.02 ± 0.13, 0.06 ± 0.17, 
0.07 ± 0.13, and 0.30 ± 0.17, respectively, in the post-LASIK 
group, and 0.71 ± 0.20, 0.09 ± 0.20, 0.11 ± 0.17, 0.11 ± 0.14, 
0.07 ± 0.12, and 0.28 ± 0.34, respectively, in the non-LASIK 
group. There was no significant difference in UNVA between 
the two groups at each postoperative examination (Student’s 
t-test, P . 0.05).
The mean (±SD) UDVA (logMAR) before CK and 
1 week, 1 month, 3 months, 6 months, and 1 year after CK 
was −0.13 ± 0.11, 0.58 ± 0.38, 0.53 ± 0.38, 0.38 ± 0.39, 
0.48 ± 0.40, and 0.07 ± 0.21, respectively, in the post-
LASIK group, and −0.07 ± 0.13, 0.65 ± 0.39, 0.53 ± 0.37, 
0.45 ± 0.34, 0.26 ± 0.24, and 0.41 ± 0.16, respectively, in 
the non-LASIK group. No significant difference was found 
in UDVA between the two groups at each postoperative 
examination (Student’s t-test, P . 0.05).
The preoperative, 6-month, and 1-year postoperative 
mean binocular UDVA (logMAR) was −0.18 ± 0.11, −0.20 ± 
0.08, and −0.18 ± 0.00 in the post-LASIK group, and −0.17 ± 
0.07, −0.09 ± 0.10, and −0.09 ± 0.12 in the non-LASIK group, 
respectively. There was a significant   difference in binocular 
UDVA between the two groups 6 months postoperatively 
(Student’s t-test, P = 0.0391).
Preoperative, 6-month, and 1-year postoperative 
mean binocular UNVA (logMAR) was 0.50 ± 0.27, 
0.06 ± 0.12, and 0.22 ± 0.25 in the post-LASIK group, and 
0.53 ± 0.22, 0.03 ± 0.10, and 0.20 ± 0.17 in the   non-LASIK 
group,   respectively. There was no significant difference 
between the two groups in binocular UNVA at each 
  postoperative examination (Student’s t-test, P . 0.05).
safety of CK
The CDVA before CK and 1 week, 1 month, 3 months, 
6 months, and 1 year after CK was measured in the post-
LASIK eyes and the non-LASIK eyes. The mean (±SD) 
preoperative CDVA (logMAR) was −0.20 ± 0.06, and 
at 1 week, 1 month, 3 months, 6 months, and 1 year 
after CK was −0.14 ± 0.06, −0.15 ± 0.08, −0.17 ± 
0.05, −0.18 ± 0.06, and −0.13 ± 0.07, respectively, in the 
  non-LASIK eyes. The mean CDVA   (logMAR) before CK 
and 1 week, 1 month, 3 months, 6 months, and 1 year after 
CK in the post-LASIK eyes was −0.22 ± 0.08, −0.15 ± 
0.06, −0.17 ± 0.07, −0.19 ± 0.04, −0.15 ± 0.08, and −0.18 ± 
0.00,   respectively. All of the post-LASIK and non-LASIK 
patients had CDVA of −0.08 (logMAR) or better throughout 
the postoperative examination period until 1 year after CK, 
and there was no significant difference between the two 
groups (Student’s t-test, P . 0.05).
The  mean  postoperative  cylindrical  changes  at 
1 week, 1 month, 3 months, 6 months, and 1 year 
after CK in the post-LASIK group were −0.30 ± 0.47 
D (±SD, range −1.00 D to +0.50 D), −0.32 ± 0.46 D 
(±SD, range −1.50 D to +0.25 D), −0.20 ± 0.28 D   Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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(±SD, range −0.75 D to +0.25 D), −0.11 ± 0.24 D (±SD, 
range −0.50 D to +0.25 D), and 0.00 ± 0.00 D (±SD), respec-
tively. The mean postoperative cylindrical changes at 1 week, 
1 month, 3 months, 6 months, and 1 year after CK in the 
non-LASIK group were −0.37 ± 0.54 D (±SD, range −1.50 D 
to +0.50 D), −0.37 ± 0.68 D (±SD, range −1.75 D to +0.75 D), 
0.00 ± 0.66 D (±SD, range −1.75 D to +0.50 D), −0.42 ± 0.52 
(±SD, range −1.50 D to +0.25 D), and −0.13 ± 0.18 (±SD, 
range −0.25 to 0.00 D), respectively. Eighty-eight percent 
(14 of 16 patients) of the non-LASIK patients had cylindri-
cal changes within ±1.00 D at 6 months postoperatively, 
and 100% (two of two patients) had cylindrical changes 
within ±0.25 D at 1 year postoperatively (Figure 1). Although 
one patient (11%) in the non-LASIK group had more than 
1.00 D of cylindrical changes, the patient maintained 
CDVA (logMAR) of −0.18 at 6 months postoperatively. 
At 6 months and 1 year postoperatively, the postoperative 
cylindrical changes were within 0.50 D and 0.00 D in all of 
the   post-LASIK patients (Figure 1).
stability of CK
The refractive changes after CK were studied at 1 week, 
1 month, 3 months, 6 months, and 1 year postopera-
tively. In the post-LASIK group, the mean MRSE before 
CK and 1 week, 1 month, and 3 months after CK was 
0.34 ± 0.44 D, −2.54 ± 1.14 D, −2.39 ± 1.07 D, −1.75 ± 
0.96 D, −1.59 ± 0.86 D, and −0.58 ± 0.52 D, respectively. 
In the non-LASIK group, the mean MRSE before CK and 
1 week, 1 month, 3 months, 6 months, and 1 year after CK 
was 0.64 ± 0.59 D, −2.09 ± 1.03 D, −1.57 ± 1.04 D, −1.46 ± 
0.73 D, −1.06 ± 0.56 D, and −1.56 ± 0.62 D, respectively. 
There was no significant difference between the two groups 
before CK and 1 week, 3 months, and 6 months after CK 
(Student’s t-test, P . 0.05). However, there was significant 
difference between the groups at 1 month postoperatively 
(Student’s t-test, P = 0.0244). In the post-LASIK group, 
the mean MRSE change between 1 week and 1 month was 
0.16 D, between 1 month and 3 months was 0.63 D, between 
3 months and 6 months was 0.16 D, and between 6 months 
and 1 year was 1.01 D, respectively. The mean MRSE change 
between 1 week and 1 month was 0.52 D, between 1 month 
and 3 months was 0.11 D, between 3 months and 6 months 
was 0.40 D, and between 6 months and 1 year was 0.50 D, 
respectively, in the non-LASIK group.
Predictability of CK
The predictability of CK was evaluated based on the clini-
cal results at 1 week, 1 month, 3 months, 6 months, and 
1 year postoperatively. The nomogram used in this study 
ranged from +0.50 D to +3.00 D, and the appropriate value 
was applied depending on the patients’ need for correction 
according to the preoperative loose lens test (Table 1). In 
the post-LASIK patients, the attempted correction was 
lowered by 20%–30% in order to avoid overcorrection. 
The mean errors in MRSE from the attempted correction 
at 1 week, 1 month, 3 months, 6 months, and 1 year post-
operatively were −1.28 ± 0.88 D, −1.12 ± 0.80 D, −0.63 ± 
0.68 D, −0.38 ± 0.82 D, and 0.00 ± 0.00 D, respectively, in 
the post-LASIK group, and −0.50 ± 0.71 D, 0.03 ± 0.98 D, 
0.29 ± 0.66 D, 0.85 ± 0.74 D, and 0.06 ± 0.80 D in the non-
LASIK group. There were significant differences between 
the two groups at 1 week, 1 month, 3 months, and 6 months 
postoperatively (Student’s t-test, P = 0.0046, 0.0007, 
0.0024, and 0.0073, respectively). The post-LASIK group 
showed greater myopic shift than the non-LASIK group.
At 6 months after CK, 44% of the eyes were within ±0.50 D, 
56% were within ±1.00 D, and 89% were within ±1.50 D 
of the intended correction, and at 1 year after CK, 50% 
were within ±0.50 D and 100% were within ±1.00 D of the 
intended correction in the non-LASIK group (Figure 2). 
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Figure 1 Cylindrical change from preoperative for non- and post-LAsiK groups. One week, 1 month, 3 months, 6 months, and 1 year postoperative absolute cylinder change 
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Table 1 nomogram for conductive keratoplasty
Intended correction Number of spots Optical zone
0.5–1.0 D 8 7 mm
1.0–1.5 D 16 7–8 mm
1.5–2.0 D 8 6 mm
2.5–3.0 D 16 6–8 mm
3.0–3.5 D 16 6–7 mm
Fifty-seven percent of the eyes were within ±0.50 D, 86% 
were within ±1.00 D, and 100% were within ±2.00 D of the 
intended correction 6 months postoperative, and 100% did 
not differ from the intended correction 1 year postoperative 
in the post-LASIK group (Figure 2).
In order to elucidate the predictability of CK, we 
  studied other factors that might have affected the clinical 
outcomes. These included pre-CK pachymetry, the amount 
of correction in the previous LASIK, and residual corneal 
bed thickness. The mean pachymetry in the non-LASIK 
group was 543.4 ± 28.7 µm (±SD, range 502–609 µm) and 
476.6 ± 50.3 µm (±SD, range 406–560 µm) in the post-
LASIK group. The mean residual corneal bed thickness was 
380 ± 45.1 µm (±SD, range 316–456 µm) and the mean 
attempted correction in the previous LASIK was 4.65 ± 2.52 D 
(±SD, range 1.25–9.50 D) in the post-LASIK group. The rela-
tionships between these factors and postoperative errors from 
the attempted correction were analyzed based on the clinical 
data at 3 months after CK (Figure 3). There was no significant 
relationship between these factors and the corrective errors of 
CK (Pearson’s correlation coefficient, P . 0.05). Furthermore, 
no relationships between the factors were observed by Spear-
man’s correlation coefficient by rank (P . 0.05).
Discussion
In recent years, a number of surgical treatments of   presbyopia 
have been reported. As LASIK has become one of the most 
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Figure 2 The error from the intended correction for non- and post-LAsiK groups. The predictability at 1 week, 1 month, 3 months, 6 months, and 1 year postoperative for 
the non- and post-LAsiK groups was evaluated by calculating the distance of manifest refraction spherical equivalent value from the intended correction.
popular choices for the correction of refractive error, we expect 
that the number of patients seeking treatment of   presbyopia 
after LASIK will increase. Some of these patients might not 
have enough residual corneal bed thickness to receive the 
second refractive correction. As CK does not   further reduce 
the residual corneal bed thickness nor does it affect the corneal 
center, CK is one of the most favorable treatments of presby-
opia after LASIK at present. However, there have been a few 
reports of comparative studies on the effects of CK between 
post-LASIK eyes and non-LASIK eyes.
All of the post-LASIK and non-LASIK patients achieved 
improvement in UNVA at 6 months after CK, and there 
was no significant difference between the two groups. The 
binocular UNVA improved in both groups at 6 months after 
CK examinations, and there was no significant difference 
between the two groups. On the whole, treatment using CK 
has improved the patients’ near vision while maintaining 
their good binocular distance vision.
The CDVA at 6 months post-CK was −0.08 (logMAR) 
or better in both groups, and there was no significant dif-
ference between the two groups. In all patients of the post-
LASIK group and 89% of the non-LASIK patients, the 
cylindrical change from preoperation was within 1.00 D at 
6 months after CK. Although the cylindrical changes were 
greater than 1.00 D in one patient of the non-LASIK group, 
the patient’s UNVA was as good as the other patients in the 
group. The patients’ visual outcomes were not affected when 
looking at the numerical results, but large cylindrical changes 
may adversely affect their quality of vision. These patients 
need to be monitored closely in the longer term.
It has been reported that the regression rate of post-CK 
patients mitigates from 3 months to 1 year after surgery.11 In 
our study, the regression rate was varied between the   examined 
period in both post-LASIK and non-LASIK groups. It is 
  suggested that regression was not a stable event after CK. Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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demonstrated that the predictability of CK on patients 
who have had previous corneal refractive surgery was not 
good.13 Although we set the target 20%–30% weaker than 
the standard nomogram, the effects of CK were stronger in 
the post-LASIK eyes than in the non-LASIK eyes, resulting 
in greater myopic shift in the post-LASIK eyes.
It has been reported that the amount of residual corneal 
thickness after LASIK and the amount of myopic correc-
tion by LASIK affect the biomechanical properties and 
strength of the cornea.14,15 Therefore, we evaluated the 
relationship between the two factors and the predictability 
of CK in the post-LASIK eyes. We demonstrated that there 
was little relationship between these two factors and the 
predictability of CK. In principle, we preserve a minimum 
of 300 µm residual corneal bed thickness after LASIK to 
allow follow-on enhancements and also for patients’ safety. 
Even with this safety margin, we assumed that the integrity 
of the cornea was weaker in the post-LASIK eyes than in 
the non-LASIK eyes, and the reduced integrity might have 
affected the predictability of the CK.
In this study, no significant relationship between the 
predictability of CK and the residual bed thickness nor the 
amount of correction by the LASIK procedure was found. 
Additionally, the relationship between corneal thickness and 
the predictability at 3 months after CK was also compared 
between the post-LASIK and the non-LASIK groups. We 
noted that there was significant difference in the mean cor-
neal thickness between the two groups. The mean corneal 
thickness for the post-LASIK group was thinner by 68.8 µm. 
The post-LASIK group also had a greater tendency to have a 
myopic shift. Even with these differences, neither group dem-
onstrated significant correlation between corneal   thickness 
and predictability.
As none of the above three factors, residual corneal 
bed thickness, amount of LASIK correction, and corneal 
  thickness, was related to the predictability of CK on post-
LASIK eyes, we hypothesize that corneal structural changes 
such as flap creation might have reduced corneal integrity 
and induced an exaggerated reaction to the CK treatment, 
leading to overcorrection. Our results were compatible with 
the hypothesis that the structural alteration of the anterior and 
posterior lamellar possibly caused an unusually large response 
to CK treatment.16 As the central corneal thickness was more 
reduced but the peripheral regions were relatively unchanged 
in LASIK, it has been suggested that corneal   elasticity has 
been decreased, and this induces a strong steepening effect, 
which could result in an approximate doubling of the effect of 
CK when compared with the effect on eyes without previous 
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Figure 3 Comparison of corneal thickness, amount of correction made during 
LAsiK, and residual corneal bed thickness after LAsiK and the predictability at 
3 months postoperative for both groups.
Further observation is needed to evaluate what may affect 
the stability of CK. Additionally, at 1 year postoperative, 
further refractive and visual (UNVA) regression was noted 
in some patients. However, they maintained good corrected 
distance and near visual acuity, suggesting that CK is a safe 
procedure.
The predictability of refractive outcomes was better in the 
non-LASIK group than in the post-LASIK group. Alió et al Clinical Ophthalmology
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Conductive keratoplasty for presbyopia
corneal surgery.17 Further investigation is needed to determine 
whether these structural changes may be the cause of the 
resultant overcorrection seen in post-LASIK eyes.
With the introduction of the special templates   (NearVison® 
CK, OptiPoint® Corneal Template) for CK probe application, 
problems such as the increased cylindrical errors caused by the 
unsymmetrical application of the probe to the cornea and/or 
the failure to mark the pupil center properly are mitigated.18
No specific intra- or postoperative complications were 
demonstrated by CK treatment on the non-LASIK nor the 
post-LASIK patients in this study. However, rare complica-
tions have been reported, such as diffuse lamellar keratitis 
followed by epithelial defects and corneal perforation after 
CK treatment on post-LASIK eyes.19,20 We need to consider 
the possibility of severe complications and carefully follow 
the post-LASIK CK patients.
In our study, few patients attended their 1-year follow-up. 
We hypothesised that those patients who did not return for 
the follow-up retained stable refraction and visual acuity and 
did not feel the need for a doctor consultation.
In conclusion, CK is demonstrated to be a safe proce-
dure for the treatment of presbyopia in post-LASIK eyes 
as well as in non-LASIK eyes. However, we need further 
  investigation into its stability and the factors that may affect 
the   predictability of CK.
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